Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2026

Investigational approaches to multiple sclerosis therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJoshua M. BoeckersBG University Hospital Bergmannsheil BochumMPMarc PawlitzkiHeinrich Heine University DüsseldorfHHHans-Peter HartungThe University of Sydney

Discussion

Loading...

Member takes

Implication

Review summarizes new treatment strategies to alter disease progression in multiple sclerosis, suggesting significant advancements.

Key Points

  • This review aims to explore and summarize emerging therapeutic strategies for multiple sclerosis.
  • Analyzed next-generation immunomodulation techniques and targeted interventions against Epstein-Barr virus.
  • Reviewed various therapeutic approaches including remyelination agents and cell-based therapies.
  • Focused on clinical trial findings and biological activity of emerging treatment candidates.
  • BTK inhibitors showed early promise in slowing MS progression by targeting inflammation.
  • CD40L blockade demonstrated decreased MRI activity in phase 2 trials.
  • Remyelination agents like clemastine had biological activity but exhibited limited clinical benefit.

Cite This Study

Boeckers et al. (2026) studied this question.

synapsesocial.com/papers/69f444d3967e944ac5567927https://doi.org/10.1097/wco.0000000000001494
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advancing the Frontiers of Multiple Sclerosis Management: Emerging Immunotherapeutic Strategies2026
  2. 2Therapeutic strategies in multiple sclerosis: a systematic review of current and emerging approaches2026 · 1 citations
  3. 3Therapeutic Advances and Biomarkers in Multiple Sclerosis2026
  4. 4Experimental Therapies in Multiple Sclerosis: Epstein–Barr Virus and Potential EBV-Related Therapeutic Strategies—A Systematic Review2026 · 1 citations
  5. 5Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies2003 · 34 citations